Synapse - Works

Results (38)

Fecal transplantation in hematopoietic transplantation

Journal Article

Peled, J. U.; van den Brink, M. R. M.
Journal of Clinical Oncology (2023)

A phase 1b study to evaluate the efficacy, safety, and pharmacokinetics of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic stem cell transplantation

Meeting Abstract

Ponce, D. M.; Kosuri, S.; Khera, N.; DeFilipp, Z. M.; Lombardo, M. J.; Ford, C. B.; Peled, J. U.; Van Den Brink, M. R. M.; von Moltke, L.; Tejura, B.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Implementing a germline testing program using fingernail specimens for patients with hematologic malignancies and initial clinical findings

Meeting Abstract

Walsh, M. F.; Fiala, E.; Birsoy, O.; Haque, T.; Stein, E. M.; Shukla, N.; Sulis, M. L.; Goldberg, A. D.; Rana, S.; Khurram, A.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Fecal microbiota transplantation for refractory immune-checkpoint-inhibitor colitis

Meeting Abstract

Elkrief, A.; Nicholas, W.; Smith, N.; Dai, A.; Slingerland, J. B.; Aleynick, N.; Lumish, M. A.; Giardina, P.; Chaft, J. E.; Chapman, P. B.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Targeting CD47 in lymphoid malignancies with CAR T cells

Meeting Abstract

Boardman, A. P.; James, S.; Van Den Brink, M. R. M.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

A phase 1b study to evaluate safety, tolerability, pharmacokinetics, and efficacy of SER-155 in adults undergoing hematopoietic stem cell transplantation to reduce the risk of infection and graft versus host disease (NCT04995653)

Meeting Abstract

Ponce, D. M.; Lombardo, M. J.; Ford, C. B.; Peled, J. U.; Van Den Brink, M. R. M.; Tejura, B.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Defining innate immune training potential as a predictor of Bacillus Calmette-Guerin immunotherapy response in nonmuscle-invasive bladder cancer

Meeting Abstract

Jiang, S.; Redelman-Sidi, G.; Pietzak, E. J.; Bochner, B. H.; Glickman, M. S.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Impact of TP53 genomic alterations in large B-cell lymphoma treated with CD19-chimeric antigen receptor T-cell therapy

Journal Article

Shouval, R.; Alarcon Tomas, A.; Fein, J. A.; Flynn, J. R.; Markovits, E.; Mayer, S.; Afuye, A. O.; Alperovich, A.; Anagnostou, T.; Besser, M. J.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Randomized phase III BMT CTN trial of calcineurin inhibitor-free chronic graft-versus-host disease interventions in myeloablative hematopoietic cell transplantation for hematologic malignancies

Journal Article

Luznik, L.; Pasquini, M. C.; Logan, B.; Soiffer, R. J.; Wu, J.; Devine, S. M.; Geller, N.; Giralt, S.; Heslop, H. E.; Horowitz, M. M.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Correlation of Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel with response and survival in rituximab relapsing or refractory EBV plus post-transplant lymphoproliferative disease (PTLD)

Meeting Abstract

Aftab, B. T.; Shen, R. R.; Guzman-Becerra, N.; Sun, Y.; Forozan, F.; Prockop, S.; Doubrovina, E.; O'Reilly, R. J.; Li, X.; Hiremath, M.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save